Design and evaluation of probe-capture sequencing for clinical Neisseria gonorrhoeae specimens

Characterizing the molecular epidemiology of Neisseria gonorrhoeae is essential for understanding disease burden, elucidating transmission dynamics, and informing clinical decision-making and public health interventions. Given that routine, culture-independent diagnostics rapidly and sensitively detect this difficult-to-cultivate pathogen, aligning genomic surveillance with these workflows is necessary to understand its epidemiology and evolutionary dynamics. To address this challenge, we investigated the utility of probe-capture sequencing to selectively enrich for pathogen-specific DNA during next-generation sequencing. Custom biotinylated oligonucleotide baits were designed using genetic information from publicly available genomes hosted on Pathogenwatch. Of the 32,574 assemblies, 2,877 representative genomes were selected to inform probe generation using core genome amino acid distance clustering and representation of unique resistance-associated genotypes and predicted resistance phenotypes. The resulting probe set provided generous coverage of the reference genome, N. gonorrhoeae FA 1090, with 94.6% nucleotide coverage and 99.3% of annotated genes covered by at least one probe. Piloting this technology on 12 clinical urine specimens with variable relative pathogen abundances revealed that probe-capture sequencing substantially increased the relative abundance of N. gonorrhoeae sequence reads from a complex sample (fold-change range, 226 - 2046), enabling considerable genome coverage, the construction of high-quality genome assemblies, and the detection of resistance-associated genotypes. These findings demonstrate that probe-capture sequencing is a viable method for enriching N. gonorrhoeae genetic material from clinical samples, enabling culture-independent genomic investigations into the epidemiology of hard-to-culture pathogens and providing actionable insights to inform clinical and public health interventions.

Authors

Institutions

Publication Details

Journal
medRxiv
Published
2026-10-30
DOI
https://doi.org/10.64898/2026.10.27.26366443
Primary Topic
Genomics and Phylogenetic Studies
Type
preprint

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
preprint

Design and evaluation of probe-capture sequencing for clinical Neisseria gonorrhoeae specimens

Brian W. Brunelle, Stefan J. Green, Kyle J. Popovich, Evan S. Snitkin et al.
1 links
medRxiv
Genomics and Phylogenetic Studies
preprint

Design and evaluation of probe-capture sequencing for clinical Neisseria gonorrhoeae specimens

Brian W. Brunelle, Stefan J. Green, Kyle J. Popovich, Evan S. Snitkin, Kyle J. Gontjes, Aryan Singh, Dhatri Badri Narayanan, Paul M Won
preprint en

Abstract

Characterizing the molecular epidemiology of Neisseria gonorrhoeae is essential for understanding disease burden, elucidating transmission dynamics, and informing clinical decision-making and public health interventions. Given that routine, culture-independent diagnostics rapidly and sensitively detect this difficult-to-cultivate pathogen, aligning genomic surveillance with these workflows is necessary to understand its epidemiology and evolutionary dynamics. To address this challenge, we investigated the utility of probe-capture sequencing to selectively enrich for pathogen-specific DNA during next-generation sequencing. Custom biotinylated oligonucleotide baits were designed using genetic information from publicly available genomes hosted on Pathogenwatch. Of the 32,574 assemblies, 2,877 representative genomes were selected to inform probe generation using core genome amino acid distance clustering and representation of unique resistance-associated genotypes and predicted resistance phenotypes. The resulting probe set provided generous coverage of the reference genome, N. gonorrhoeae FA 1090, with 94.6% nucleotide coverage and 99.3% of annotated genes covered by at least one probe. Piloting this technology on 12 clinical urine specimens with variable relative pathogen abundances revealed that probe-capture sequencing substantially increased the relative abundance of N. gonorrhoeae sequence reads from a complex sample (fold-change range, 226 - 2046), enabling considerable genome coverage, the construction of high-quality genome assemblies, and the detection of resistance-associated genotypes. These findings demonstrate that probe-capture sequencing is a viable method for enriching N. gonorrhoeae genetic material from clinical samples, enabling culture-independent genomic investigations into the epidemiology of hard-to-culture pathogens and providing actionable insights to inform clinical and public health interventions.

medRxiv
University of Michigan (US), Rush University (US)
National Human Genome Research Institute, National Institute of Allergy and Infectious Diseases
Good health and well-being
Genomics and Phylogenetic Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon